Grantham, Mayo, Van Otterloo & Co (GMO)’s CATALENT, INC. CTLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-343,016
Closed -$20.8M – 624
2024
Q3
$20.8M Sell
343,016
-123,735
-27% -$7.32M 0.07% 192
2024
Q2
$26.2M Buy
+466,751
New +$26M 0.09% 153
2018
Q4
– Sell
-17,400
Closed -$793K – 599
2018
Q3
$793K Sell
17,400
-4,300
-20% -$182K 0.01% 396
2018
Q2
$909K Sell
21,700
-41,100
-65% -$1.66M 0.01% 376
2018
Q1
$2.58M Buy
62,800
+45,400
+261% +$1.93M 0.02% 293
2017
Q4
$715K Buy
17,400
+10,000
+135% +$407K ﹤0.01% 400
2017
Q3
$295K Buy
+7,400
New +$274K ﹤0.01% 481

Other funds holding CTLT

Grantham, Mayo, Van Otterloo & Co (GMO)'s CTLT Position: Q4 2024 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of CATALENT, INC. (CTLT) in Q4 2024, closing a stake of 343,016 shares — an estimated $20.8M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CTLT in Q3 2017 and held it in 7 quarters. The position peaked at $26.2M in Q2 2024. 6 funds tracked by Wall St. Rank hold CTLT as of Q4 2024.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining CATALENT, INC. position as of Q4 2024 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 343,016 CATALENT, INC. shares in Q4 2024, an estimated $20.8M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CATALENT, INC. in Q3 2017 and held it in 7 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s CATALENT, INC. position peaked at $26.2M in Q2 2024.
  • 6 funds tracked by Wall St. Rank held CATALENT, INC. as of Q4 2024.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2024, filed 13 Feb 2025.